Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis.
Cognitive impairment in relapsing remitting and secondary progressive multiple sclerosis patients: efficacy of a computerized cognitive screening battery.
Molecular pathogenesis of neuromyelitis optica.
Association of urodynamic findings in new onset multiple sclerosis with subsequent occurrence of urinary symptoms and acute episode of disease in females.
The myelin mutants as models to study myelin repair in the leukodystrophies.
Value of the MoCA Test as a Screening Instrument in Multiple Sclerosis.
Pilot study of minocycline in relapsing-remitting multiple sclerosis.
The Treatment experience, burden, and unmet needs (TRIBUNE) study - measuring the socioeconomic consequences of Multiple Sclerosis.
Cognitive deficit is related to immune-cell beta-NGF in multiple sclerosis patients.
The impact of osteopontin gene variations on multiple sclerosis development and progression.
Positive Effect on Multiple Sclerosis With Treatment of Metabolic Syndrome.
Primaquine treatment suppresses experimental autoimmune encephalomyelitis severity.
[Optic Neuritis.]
Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review.
Bioenergetics of the spinal cord in experimental autoimmune encephalitis of rats.
Responsiveness and Clinically Meaningful Improvement, According to Disability Level, of Five Walking Measures After Rehabilitation in Multiple Sclerosis: A European Multicenter Study.
Therapeutic strategies of urinary disorders in MS. Practice and algorithms.
Music mnemonics aid Verbal Memory and Induce Learning - Related Brain Plasticity in Multiple Sclerosis.
CNS demyelinating disorder with mixed features of neuromyelitis optica and multiple sclerosis in HIV-1 infection. Case report and literature review.
Treg cell resistance to apoptosis in DNA vaccination for experimental autoimmune encephalomyelitis treatment.
Color blindness among multiple sclerosis patients in Isfahan.
Sphingosine-1-Phosphate Links Persistent STAT3 Activation, Chronic Intestinal Inflammation, and Development of Colitis-Associated Cancer.
Multiple sclerosis: T-cell resistance to regulation in RRMS linked to IL-6 pathway.
Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis.
1,25-Dihydroxyvitamin D3 Suppresses TLR8 Expression and TLR8-Mediated Inflammatory Responses in Monocytes In Vitro and Experimental Autoimmune Encephalomyelitis In Vivo.
Pages
« first
‹ previous
…
260
261
262
263
264
265
266
267
268
…
next ›
last »